Doctors Revision

Macrolides, Lincosamides, Quinolones, Tetracyclines and Other Antibacterials

Text size
On this page

Overview

Figure 1: Bacterial ribosome and DNA diagram showing macrolides and clindamycin on the 50S subunit, tetracyclines on the 30S subunit, and quinolones blocking DNA gyrase
Figure 1: Where this note's classes act — 50S, 30S and the DNA gyrase complex.

Macrolides in detail

Macrolides bind the 50S subunit, blocking translocation — bacteriostatic at usual doses. They concentrate intracellularly, so they excel against atypical pathogens (Mycoplasma, Chlamydia, Legionella) and penetrate respiratory secretions.

Scroll the table sideways on a smaller screen.

The macrolides: dose, indications, adverse effects, contraindications, counselling
DrugAdult dose (usual)Paediatric doseMain indicationsSide & adverse effectsContraindications & cautionsCounselling
Erythromycin (Watch)250–500 mg 6-hourly oral (base); IV per protocol. Atypical pneumonia, pertussis, campylobacteriosis10–12.5 mg/kg 6-hourlyAtypical pneumonia, pertussis (whooping cough), campylobacteriosis, chlamydial infection; gastric-motility stimulant (erythromycin low-dose) in feeding intoleranceGI upset and promotility effect (cramps, diarrhoea) via motilin; reversible cholestatic jaundice (class effect, esp. longer courses); QT prolongation (torsades risk); transient deafness at high dose/renal failureQT-prolonging drugs or hypokalaemia (torsades); hepatic impairment; caution with statins (rhabdomyolysis — avoid simvastatin)Take with food if nauseated but avoid heavy meals (reduces absorption); report palpitations, fainting, yellow eyes; complete course
Azithromycin (Watch)500 mg once daily ×3 days (or 500 mg day 1 then 250 mg days 2–5); single-dose 1 g for chlamydia (per STI guidelines)10 mg/kg once daily ×3 daysAtypical pneumonia, pertussis, chlamydial infection/STI syndromes, traveller's diarrhoea, trachoma (mass treatment), severe enteric fever alternativeMuch better tolerated than erythromycin (no motilin stimulation); GI upset, rare QT prolongation, transient hearing change at high cumulative doseQT-prolongation risk as above; macrolide allergyShort course aids adherence; avoid antacids within 2 h (aluminium/magnesium reduce absorption)
Clarithromycin (Watch)250–500 mg 12-hourly ×7–14 days7.5 mg/kg 12-hourlyH. pylori eradication (combination), atypical pneumonia, sinusitis/otitis second line, nontuberculous mycobacteria (specialist)GI upset, taste disturbance (metallic — characteristic), QT prolongationAs azithromycin; strong CYP3A4 inhibitorTaste change is expected and resolves; avoid statins; report palpitations

Lincosamides: clindamycin

Clindamycin also binds the 50S subunit (adjacent site) and is the key lincosamide. It achieves excellent bone, skin and abscess penetration and covers anaerobes and most streptococci/staphylococci (MRSA included in many regions) — but not enteric Gram-negatives.

Scroll the table sideways on a smaller screen.

Clindamycin: the essentials
ItemDetails
DoseAdult 150–450 mg 6–8-hourly oral; severe 600 mg–1.2 g IV q8h. Child: 10–30 mg/kg/day divided q6–8h
IndicationsStaphylococcal/streptococcal skin and soft-tissue infection, toxin suppression in streptococcal toxic shock and necrotising fasciitis (with a cell-wall agent), anaerobic infection above the diaphragm, dental abscess (penicillin-allergic), severe malaria adjunct (quinine combinations) per national guidance
Adverse effectsClostridioides difficile colitis — the signature risk (disrupts colon flora); diarrhoea must trigger review and a C. difficile test; rash, oesophagitis (take with water, stay upright 30 min)
Contraindications / cautionsPrior C. difficile colitis; previous clindamycin-associated colitis; hepatic impairment (dose-adjust); not for meningitis or UTI (poor CSF/urine penetration)
Resistance noteConstitutive erm-mediated MLSB resistance → inducible clindamycin resistance in some staphylococci — severe streptococcal disease should get a macrolide-lincosamide-streptogramin B (D-zone/MLS) assessment where available

Quinolones in detail

Quinolones inhibit DNA gyrase (topoisomerase II) and topoisomerase IV, preventing supercoil relaxation and bacterial replication — bactericidal, concentration-dependent. Fluorinated derivatives ("fluoroquinolones") have the Gram-negative power.

Scroll the table sideways on a smaller screen.

The fluoroquinolones: dose, indications, adverse effects, contraindications, counselling
DrugAdult dose (usual)Paediatric doseMain indicationsSide & adverse effectsContraindications & cautionsCounselling
Ciprofloxacin (Watch)Dysentery/shigellosis: 500 mg 12-hourly ×3 days. Complicated UTI/pyelonephritis: 500–750 mg 12-hourly. Typhoid (sensitive or with susceptibility): 500 mg 12-hourly; severe 400 mg IV q8–12hGenerally reserved for children (cartilage caution): 10–15 mg/kg 12-hourly for dysentery, short coursesDysentery (first line per UCG for bloody diarrhoea), travel/complicated UTI, enteric fever, cholera adjunct, Gram-negative sepsis (with a beta-lactam), anthrax (post-exposure)Nausea, diarrhoea, headache, dizziness; tendinitis and tendon rupture (Achilles — stop at first tendon pain); QT prolongation; dysglycaemia (rare); C. difficile; peripheral neuropathy (rare); chelation by antacids/iron/zinc/calcium/dairy — markedly reduces absorptionPregnancy and breastfeeding (cartilage); children except specific short-course indications; epilepsy (lowers seizure threshold at high dose); QT-prolonging drugs; myasthenia gravis exacerbation; avoid concomitant tizanidineTake with water, 2 h away from antacids, iron, zinc, calcium and dairy; report tendon pain, palpitations, severe diarrhoea; complete course; avoid excessive sun
Levofloxacin (Watch)500 mg once daily ×7–14 days (CAP, UTI per susceptibility)8–10 mg/kg once daily (selected indications)Community-acquired pneumonia (including penicillin-resistant pneumococcus), complicated UTI, TB second-line (fluoroquinolone class)Same class profile; prominent QT prolongation; insomnia and agitation reportedAs ciprofloxacinAs ciprofloxacin; report new confusion or palpitations

Tetracyclines in detail

Tetracyclines bind the 30S subunit, blocking amino-acyl-tRNA docking — bacteriostatic, broad-spectrum (including atypicals, rickettsiae, spirochaetes), and exceptionally well distributed into tissues.

Scroll the table sideways on a smaller screen.

Doxycycline: the essential tetracycline (Access list)
ItemDetails
DoseAdult 100 mg 12-hourly (day 1 may be 200 mg); many courses 7–14 days. Child >8 years: 2–4 mg/kg/day divided 12-hourly (short courses >8 y and <45 kg per protocol)
IndicationsAtypical pneumonia, chlamydia (and syphilis alternative — 100 mg bd ×14 days if penicillin-allergic), rickettsioses (tick-borne relapsing fever), brucellosis (combination), acne, rosacea, chloroquine-resistant malaria prophylaxis, some cholera adjunct regimens
Side & adverse effectsOesophagitis/ulceration (take with water, upright), nausea, photosensitivity (sunburn on exposure — counsel), Candida overgrowth; benign intracranial hypertension (rare); permanent teeth staining and growth effects in children <8 years and in the fetus (third trimester)
Contraindications / cautionsPregnancy and breastfeeding; children <8 years (except short courses for rickettsiosis where benefit outweighs); severe hepatic impairment (large IV doses)
InteractionsChelation: antacids, iron, calcium, magnesium, zinc and dairy slash absorption — separate by 2–3 h; warfarin potentiation (monitor INR); reduced efficacy of oral contraceptives during vomiting/diarrhoea

Chloramphenicol, nitrofurantoin and metronidazole

Scroll the table sideways on a smaller screen.

Chloramphenicol, nitrofurantoin and metronidazole: essentials
DrugDose (adult / child)IndicationsSide & adverse effectsContraindications / counselling
Chloramphenicol (Access)Adult 500 mg–1 g 6-hourly (meningitis per UCG: 1 g q6h); child 25–50 mg/kg/day divided q6h (meningitis 100 mg/kg/day). Eye drops for conjunctivitisBacterial meningitis when ceftriaxone unavailable (with benzylpenicillin per UCG), typhoid (sensitive strains, alternative), rickettsioses, eye infection (topical)Aplastic anaemia (idiosyncratic, dose-independent, ~1:25,000 — the feared late effect), grey baby syndrome in neonates (immature glucuronidation → circulatory collapse — avoid in the newborn), dose-related marrow suppression (reversible), optic neuritisAvoid in neonates (grey baby) and pregnancy near term; check FBC on courses >14 days; never for trivial infections; report bruising, sore throat, pallor
Nitrofurantoin (Access)Simple UTI (cystitis): 100 mg 12-hourly ×5–7 days; prophylaxis 50–100 mg at night. Child: 5–7 mg/kg/day divided q6hLower UTI only — achieves high urinary but poor tissue levelsNausea (common — take with food), orange-brown urine (harmless — counsel), peripheral neuropathy (renal impairment), rare pulmonary reactions and hepatitis; haemolysis in G6PD deficiencyOnly if cystitis confirmed (never pyelonephritis — inadequate tissue levels); avoid in renal impairment (CrCl <30–45 mL/min) and G6PD deficiency; take with food and fluids
Metronidazole (Access)Adult 400–500 mg 8-hourly ×7 days (amoebiasis, giardiasis, trichomoniasis); anaerobic infection 500 mg 8-hourly IV; C. difficile 400–500 mg 8-hourly ×10–14 days. Child 7.5–15 mg/kg 8-hourlyProtozoa (amoebiasis, giardiasis, trichomoniasis — see antiparasitic posts) and anaerobic bacteria (intra-abdominal/pelvic sepsis, dental abscess, C. difficile, H. pylori component)Metallic taste, nausea, furry tongue, dark urine; peripheral neuropathy (prolonged courses); disulfiram-type reaction with alcohol (flushing, vomiting, tachycardia — avoid alcohol during and 48 h after); encephalopathy at high cumulative dosesAvoid alcohol during and 48 h after the course; warfarin potentiation (monitor INR); caution in hepatic impairment

Cross-cutting interactions and counselling

Scroll the table sideways on a smaller screen.

The interactions examiners ask about
ClassInteractionEffect & action
Macrolides (esp. erythromycin, clarithromycin)Statins (simvastatin), theophylline, carbamazepine, warfarin, CYP3A4 substratesCYP3A4 inhibition raises substrate levels — rhabdomyolysis with simvastatin (avoid combination), theophylline toxicity, raised INR; QT-additive with amiodarone, sotalol, fluconazole, antipsychotics
QuinolonesAntacids, iron, zinc, calcium, dairy; NSAIDs (seizures); warfarin; QT drugsChelation — separate by ≥2–4 h; NSAIDs lower seizure threshold; monitor INR; avoid QT stacking
TetracyclinesAntacids/iron/calcium (chelation); warfarin; retinoids (benign intracranial hypertension)Separate by 2–3 h; monitor INR; avoid isotretinoin co-prescription
MetronidazoleAlcohol; warfarin; lithiumDisulfiram reaction — counsel abstinence 48 h beyond the course; raised INR; raised lithium

Clinical scenarios

Scenario 1 — Atypical pneumonia in a young adult

A 20-year-old student has 2 weeks of dry cough, low-grade fever and headache; chest X-ray shows patchy consolidation. The insidious course and absent toxic appearance suggest Mycoplasma pneumoniae. You treat with azithromycin 500 mg daily ×3 days (or doxycycline 100 mg bd ×7 days — both cover atypicals), counsel to report palpitations (QT), and advise returning if breathlessness worsens. A beta-lactam would have failed — Mycoplasma has no cell wall: a classic application of the targets map.

Scenario 2 — Bloody diarrhoea at the health centre

A 6-year-old has fever and bloody, mucoid stools — dysentery, most likely shigellosis. Per UCG you give ciprofloxacin (child: short-course per protocol) plus ORS and zinc, and counsel the mother to separate the dose from any antacid or iron by 2 hours. Three days later the child is well. The stewardship lesson: quinolones are justified here (invasive bacterial diarrhoea) — not for watery viral diarrhoea, where they add only risk.

Scenario 3 — Clindamycin and the warning diarrhoea

A 45-year-old on day 4 of clindamycin for a staphylococcal skin abscess develops profuse watery diarrhoea and cramping. You suspect C. difficile colitis, stop the clindamycin, send a stool test, start metronidazole (or oral vancomycin per protocol) if confirmed, and isolate as infection-control dictates. The teaching point: any antibiotic can cause it, but clindamycin, fluoroquinolones and broad-spectrum cephalosporins are the classic culprits — counsel patients at the start, not after.

Key points

References

  • WHO AWaRe Antibiotic Book, 2022/2023 — atypical pneumonia, dysentery and STI regimens (Library reference.)
  • Uganda Clinical Guidelines 2023: STI, diarrhoeal disease and meningitis chapters (Library reference.)
  • Uganda Essential Medicines and Health Supplies List 2023 (Library reference.)
  • Katzung's Basic & Clinical Pharmacology — macrolide, quinolone and tetracycline chapters (Library reference.)
  • Goodman & Gilman's The Pharmacological Basis of Therapeutics (Library reference.)

Further reading

For deeper study, compare this lesson with current guidance and standard references from recognised medical and pharmaceutical organisations.

For education only. Doses change with guideline updates — always verify against the current Uganda Clinical Guidelines, the EMHSLU 2023 and your facility formulary before prescribing.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top